OQROGet OQRO Pro
Insider trade

Passage Bio (PASG)10% owner bought ~$71K

Lynx1 Capital Management LP, 10% owner at Passage Bio, bought ~$71K of Passage Bio shares.

~$71K
Approx. value · 13K sh @ $5.44
476K
Holds after · shares reported
Traded
Jul 22, 2025
Filed
Jul 24, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Jun 24, 2025Insider10% owner sold ~$81K of PASG shares in the open market
  2. Jun 25, 2025Insider10% owner sold ~$46K of PASG shares in the open market
  3. Jun 26, 2025Insider10% owner sold ~$70K of PASG shares in the open market
  4. Jul 22, 2025 · this disclosureInsider10% owner purchased ~$71K of PASG shares in the open market

What came next

  1. Jul 23, 2025Insider10% owner purchased ~$283K of PASG shares in the open market
  2. Jul 24, 2025Insider10% owner purchased ~$379K of PASG shares in the open market
  3. Sep 11, 2025Insider · 5 days before an 8-K10% owner purchased ~$2.3K of PASG shares in the open market
  4. Sep 12, 2025Insider · 4 days before an 8-K10% owner purchased ~$138K of PASG shares in the open market
  5. Sep 15, 2025Insider · 1 day before an 8-K10% owner purchased ~$83K of PASG shares in the open market
  6. Sep 16, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“On September 16, 2025, Saqib Islam notified Passage Bio, Inc. (the “ Company ”) of his decision to resign from the Company’s Board of Directors (the “ Board ”), including from the Audit Committee of the Board (the “ Audit Committee ”), effective immediately (the “ Resignation Date ”).”
  7. Nov 10, 2025Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Passage Bio

OQRO holds no insider, Congress, fund or contract record for Passage Bio dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its PASG page.

Other recent filings by Lynx1 Capital Management LP, 10% owner

The full history of Lynx1 Capital Management LP, 10% owner is on the profile page.

How this filing works

Other disclosures at Passage Bio

Everything OQRO holds on this company is on its PASG page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data